市场调查报告书

止血剂·组织密封胶的全球市场的未来预测

Global Hemostats and Tissue Sealants Market Forecast 2019-2027

出版商 Inkwood Research 商品编码 750058
出版日期 内容资讯 英文 135 Pages
商品交期: 2-3个工作天内
价格
Back to Top
止血剂·组织密封胶的全球市场的未来预测 Global Hemostats and Tissue Sealants Market Forecast 2019-2027
出版日期: 2019年02月16日内容资讯: 英文 135 Pages
简介

本报告提供全球止血剂及组织密封胶 (组织密封胶) 市场未来展望相关分析,提供产品概要和市场结构,主要的推动及阻碍市场要素,整体市场规模趋势预测 (今后9年份),各产品及地区别详细趋势,市场竞争环境,主要企业简介等调查。

第1章 分析范围

第2章 分析方法

第3章 摘要整理

第4章 市场动态

  • 市场范围和定义
  • 推动市场要素
  • 阻碍市场要素
  • 市场机会
  • 市场课题

第5章 各产品的市场

  • 局部止血剂
    • 机械性止血法
    • 活性止血剂
    • 流动性止血剂
  • 黏剂·组织密封胶
    • 合成组织密封胶
      • 氧化再生纤维素
      • 氰基丙烯酸酯黏剂
      • 其他
    • 天然组织密封胶
      • 甲壳素品质/几丁聚糖系的止血剂
      • 其他
    • 粘连防止产品

第6章 主要指标

  • 波特的五力分析
  • PESTLE/SCOT分析:止血剂·组织密封胶市场
    • 政治·法律上的要素
    • 经济要素
    • 技术性要素
  • 市场趋势
  • 市场机会矩阵

第7章 各地区分析

  • 北美 (美国,加拿大)
  • 欧洲 (英国,德国,法国,义大利,西班牙等)
  • 亚太地区 (日本,中国,印度,澳洲,韩国等)
  • 其他的国家 (RoW:南美,中东·非洲)

第8章 竞争环境

  • 市场定位分析
  • 企业简介
    • ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
      • 企业概要
      • 产品系列
      • SCOT分析
      • 策略部署情形
    • BAXTER INTERNATIONAL INC.
    • B.BRAUN MELSUNGEN AG
    • COHERA MEDICAL INC.
    • C.R. BARD, INC.
    • CRYOLIFE INC.
    • CSL BEHRING
    • HYPERBRANCH MEDICAL TECHNOLOGY, INC. (STRYKER收购完毕)
    • INTEGRA LIFESCIENCES CORP
    • JOHNSON AND JOHNSON
    • MEDTRONIC PLC
    • PFIZER, INC.
    • SMITH AND NEPHEW PLC
    • ZIMMER BIOMET HOLDINGS INC

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 22676

KEY FINDINGS

The global market for hemostats and sealants is predicted to grow at a CAGR of 8.03% between 2019 and 2027. The increasing cases of chronic diseases requiring surgeries are primarily driving the global hemostats and sealants market. The market has been segmented on the basis of its products into topical hemostat and adhesive & tissue sealants. The synthetic skin sealants sub-segment, under the adhesive & tissue sealants category, is flourishing the most in terms of revenues and was valued at $xx million in 2018.

MARKET INSIGHTS

The predicted rise in global geriatric population is expected to drive the growth of hemostasis and tissue sealing market over the forecast period in both the developed economies and emerging economies like that of India and China. The increasing numbers of minimally-invasive cosmetic procedures are expected to propel the number of surgeries in the global healthcare market, which is further expected to propel the market for hemostats and sealants. Nonetheless, the grafting of the sealants in the body can cause serious medical complications, resulting in their increased scrutiny for safety and effectiveness. This can act as a hurdle for the market to overcome.

REGIONAL INSIGHTS

The global market for hemostats and tissue sealants is geographically segmented into several regions, namely, North America, Asia-Pacific, Europe and the countries from the Rest of the World. North America is expected to capture the largest share of the global hemostasis and tissue sealing agents market mainly because of the increasing cases of cardiovascular disorders, diabetes and cancer in this region. The Asia Pacific market has been projected to grow at a good pace during the forecast period owing to the better medical tourism and surgical procedures. The European market is expected to grow due to the upsurge in its geriatric population, which will result in a higher frequency of surgeries being performed.

COMPETITIVE INSIGHTS

Most of the market players operate through segments that can be involved in discovery, development and manufacture of healthcare products. Some of these companies are Advanced Medical Solutions (AMS) Group PLC, Baxter International Inc., B.Braun Melsungen AG, Cohera Medical Inc., C.R. Bard, Inc., Cryolife Inc., CSL Behring, Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Integra Lifesciences Corp., Johnson & Johnson, Medtronic PLC, Pfizer, Inc. and Smith & Nephew PLC.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
    • 3.2.2. SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 4.2.2. INCREASE IN AGING POPULATION
    • 4.2.3. INCREASE IN NUMBER OF SURGERIES
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. STRINGENT REGULATIONS
    • 4.3.2. ADVERSE REACTIONS AND COMPLICATIONS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
    • 4.4.2. ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
    • 4.5.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY

5. MARKET BY PRODUCTS

  • 5.1. TOPICAL HEMOSTAT
    • 5.1.1. MECHANICAL HEMOSTATS
    • 5.1.2. ACTIVE HEMOSTATS
    • 5.1.3. FLOWABLE HEMOSTATS
  • 5.2. ADHESIVE AND TISSUE SEALANTS
    • 5.2.1. SYNTHETIC TISSUE SEALANT
      • 5.2.1.1. OXIDIZED REGENERATED CELLULOSE
      • 5.2.1.2. CYANOACRYLATE ADHESIVES
      • 5.2.1.3. OTHER SYNTHETIC TISSUE SEALANTS
    • 5.2.2. NATURAL TISSUE SEALANT
      • 5.2.2.1. CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
      • 5.2.2.2. OTHER NATURAL TISSUE SEALANT
    • 5.2.3. ADHESION BARRIER PRODUCTS

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCE MODEL
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTE
    • 6.1.3. BARGAINING POWER OF SUPPLIERS
    • 6.1.4. BARGAINING POWER OF BUYERS
    • 6.1.5. THREAT OF COMPETITIVE RIVALRY
  • 6.2. POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SCOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
    • 6.2.1. POLITICAL & LEGAL
    • 6.2.2. ECONOMIC
    • 6.2.3. TECHNOLOGICAL
  • 6.3. MARKET TRENDS
  • 6.4. OPPORTUNITY MATRIX

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. GERMANY
    • 7.2.3. FRANCE
    • 7.2.4. ITALY
    • 7.2.5. SPAIN
    • 7.2.6. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. JAPAN
    • 7.3.2. CHINA
    • 7.3.3. INDIA
    • 7.3.4. AUSTRALIA
    • 7.3.5. SOUTH KOREA
    • 7.3.6. REST OF ASIA PACIFIC
  • 7.4. REST OF THE WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST AND AFRICA

8. COMPETITIVE LANDSCAPE

  • 8.1. MARKET POSITION ANALYSIS
  • 8.2. COMPANY PROFILES
    • 8.2.1. ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
      • 8.2.1.1. COMPANY OVERVIEW
      • 8.2.1.2. PRODUCT PORTFOLIO
      • 8.2.1.3. STRATEGIC INITIATIVES
    • 8.2.2. BAXTER INTERNATIONAL INC.
      • 8.2.2.1. COMPANY OVERVIEW
      • 8.2.2.2. PRODUCT PORTFOLIO
      • 8.2.2.3. SCOT ANALYSIS
      • 8.2.2.4. STRATEGIC INITIATIVES
    • 8.2.3. B.BRAUN MELSUNGEN AG
      • 8.2.3.1. OVERVIEW
      • 8.2.3.2. PRODUCT PORTFOLIO
      • 8.2.3.3. SCOT ANALYSIS
      • 8.2.3.4. STRATEGIC ANALYSIS
    • 8.2.4. COHERA MEDICAL INC.
      • 8.2.4.1. COMPANY OVERVIEW
      • 8.2.4.2. PRODUCT PORTFOLIO
      • 8.2.4.3. STRATEGIC INITIATIVES
    • 8.2.5. C.R. BARD, INC.
      • 8.2.5.1. COMPANY OVERVIEW
      • 8.2.5.2. PRODUCT PORTFOLIO
      • 8.2.5.3. SCOT ANALYSIS
      • 8.2.5.4. STRATEGIC INITIATIVES
    • 8.2.6. CRYOLIFE INC.
      • 8.2.6.1. COMPANY OVERVIEW
      • 8.2.6.2. PRODUCT PORTFOLIO
      • 8.2.6.3. STRATEGIC INITIATIVES
    • 8.2.7. CSL BEHRING
      • 8.2.7.1. COMPANY OVERVIEW
      • 8.2.7.2. PRODUCT PORTFOLIO
      • 8.2.7.3. STRATEGIC INITIATIVES
    • 8.2.8. HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
      • 8.2.8.1. COMPANY OVERVIEW
      • 8.2.8.2. PRODUCT PORTFOLIO
      • 8.2.8.3. STRATEGIC INITIATIVES
    • 8.2.9. INTEGRA LIFESCIENCES CORP
      • 8.2.9.1. COMPANY OVERVIEW
      • 8.2.9.2. PRODUCT PORTFOLIO
      • 8.2.9.3. SCOT ANALYSIS
      • 8.2.9.4. STRATEGIC INITIATIVES
    • 8.2.10. JOHNSON AND JOHNSON
      • 8.2.10.1. COMPANY OVERVIEW
      • 8.2.10.2. PRODUCT PORTFOLIO
      • 8.2.10.3. SCOT ANALYSIS
      • 8.2.10.4. STRATEGIC INITIATIVES
    • 8.2.11. MEDTRONIC PLC
      • 8.2.11.1. COMPANY OVERVIEW
      • 8.2.11.2. PRODUCT PORTFOLIO
      • 8.2.11.3. SCOT ANALYSIS
      • 8.2.11.4. STRATEGIC INITIATIVES
    • 8.2.12. PFIZER, INC.
      • 8.2.12.1. COMPANY PROFILES
      • 8.2.12.2. PRODUCT PORTFOLIO
      • 8.2.12.3. SCOT ANALYSIS
      • 8.2.12.4. STRATEGIC INITIATIVES
    • 8.2.13. SMITH AND NEPHEW PLC
      • 8.2.13.1. MARKET OVERVIEW
      • 8.2.13.2. PRODUCT PORTFOLIO
      • 8.2.13.3. SCOT ANALYSIS
      • 8.2.13.4. STRATEGIC INITIATIVE
    • 8.2.14. ZIMMER BIOMET HOLDINGS INC
      • 8.2.14.1. MARKET OVERVIEW
      • 8.2.14.2. PRODUCT PORTFOLIO
      • 8.2.14.3. SCOT ANALYSIS
      • 8.2.14.4. STRATEGIC INITIATIVES

LIST OF TABLES

  • TABLE 1 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
  • TABLE 3 GLOBAL TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL TOPICAL HEMOSTAT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL MECHANICAL HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL ACTIVE HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL FLOWABLE HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL CYANOACRYLATE ADHESIVES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL OTHER SYNTHETIC TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL NATURAL TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL OTHER NATURAL TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 22 EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 23 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 24 REST OF THE WORLD HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 25 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
  • TABLE 26 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)

LIST OF FIGURES

  • FIGURE 1 PROCESS OF COAGULATION
  • FIGURE 2 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2018-2026 ($ MILLION)
  • FIGURE 3 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
  • FIGURE 4 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
  • FIGURE 17 PORTER'S FIVE FORCE MODEL
  • FIGURE 18 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 19 THE UNITED STATES HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 20 CANADA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 21 THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 22 GERMANY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 23 FRANCE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 24 ITALY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 25 SPAIN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 26 REST OF EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 27 JAPAN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 28 CHINA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 INDIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 AUSTRALIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 SOUTH KOREA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 REST OF ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 LATIN AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 MIDDLE EAST AND AFRICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
Back to Top